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Abstract
Hepatitis D virus (HDV) infection is present worldwide 
and affects all age groups. Around 18 million people 
are estimated to be infected with HDV. An important 
trend in HDV infection is global decline. HDV prevalence 
has decreased significantly in Europe since the 1970s 
and 1980s when it was first reported. The Asia-Pacific 
region now seems to be where HDV is a major health 
concern. There is a lack of available data from most of 
the countries from this region; hence, the true status 
of HDV cannot be determined. In South Asia, most of 
the countries have conditions that are favorable for 
the spread of hepatitis B and other related infections. 
Countries like Pakistan and Iran have shown an increase 
in HDV prevalence over a period of time. Other countries 
and region like China, Turkey, Australia, Japan, India and 
Taiwan, some of which had very high HDV prevalence 
in the past, have shown a decline in the incidence, but 
high prevalence persists in some. Intravenous drug 
abusers, homosexual men and women, prostitutes, and 
people on hemodialysis are the groups with very high 
HDV prevalence. 
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INTRODUCTION
Hepatitis D virus (HDV) infection is present worldwide 
and affects all age groups. However, it does not have 
uniform distribution and its general pattern is parallel to 
that of  hepatitis B virus (HBV). Its prevalence is highest 
in some parts of  Africa, South America, Romania, Russia 
and the Mediterranean region included Southern Italy[1]. 
It is also noteworthy that approximately 5% of  the 
global HBV carriers are co-infected with HDV. Out of  
approximately 350 million carriers of  HBV worldwide, 
18 million people are infected with HDV[2].
Hepatitis D prevalence has declined significantly in 
Europe since the 1970s and 1980s when it was first re-
ported. The new foci of  infection now seem to be in the 
developing countries. The Asia-Pacific region seems to be 
where HDV exists with high prevalence rates in some of  
the countries[3].
HDV
HDV is also known as hepatitis delta virus, and is a 
defective RNA virus that requires HBV for its virion 
assembly and penetration into hepatocytes[4]. There are 
three genotypes of  HDV, identified on the basis of  
analysis of  HDV genomes from various parts of  the 
world[5]. The most prevalent worldwide is genotype Ⅰ, 
which is related to a broad spectrum of  pathogenicity. 
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The United States, Middle East and Europe are the places 
where genotype Ⅰ is predominant, with some geographi-
cally based subtypes[6,7]. Genotype Ⅱ is predominant in 
the Far East[5]. Genotype Ⅲ is associated with severe 
forms of  hepatitis and is predominant in Northern South 
America[8].
GLOBAL TREND OF DECLINE
An important trend in worldwide HDV infection is a 
global decline in the prevalence of  hepatitis D infection, 
which is true for both acute and chronic forms of  the 
disease[9]. This decreasing trend is the result of  global 
HBV vaccination, increasing awareness, improved 
prevention strategies and socioeconomic conditions[10]. 
Italy, which was considered a traditionally prevalent area 
for HDV and where the virus was first reported, has 
shown a steady decline in the prevalence of  this infection 
from 23% in 1987 to 14% in 1992 and 8.3% in 1997[11-13]. 
Figure 1 summarizes the prevalence of  hepatitis D in the 
Asia-Pacific region, incorporating the recent data.
HDV IN PAKISTAN
In South Asia, most of  the countries offer conditions 
that are favorable for the spread of  hepatitis B and other 
related infections. These conditions mainly include lack of  
defensive strategies and approaches for these infections, 
extreme and persistent poverty, densely populated 
areas, and deteriorating public health and educational 
infrastructure. According to a study conducted from 
January 1994 to April 2001, the prevalence of  HDV 
infection in Pakistani hepatitis B surface antigen (HBsAg)-
positive individuals was 16.6%. A large belt with high 
prevalence exists in the middle of  the country, which 
comprises rural areas[10]. The predominant genotype of  
HDV is genotype Ⅰ and that of  HBV is genotype D[5].
A recently conducted study shows a very high HDV 
prevalence of  58.6% in HBsAg-positive patients who 
visited liver clinics in Karachi and Jacobabad. The 
study showed a higher prevalence compared to that 
in a previous study by Mumtaz et al[10]. The prevalence 
in these patients coming from districts of  Sindh and 
Balochistan Provinces was 67% in Jacobabad, 65.4% in 
Jafferabad, 60% in Naseerabad, 69.2% in Kashmore, 
65.2% in Quetta and 36.6% in Karachi[14].
The high prevalence could be due to the frequent 
use of  therapeutic injections and drips, contaminated 
needles, surgical and dental equipment, reusing traditional 
razors by barbers, use of  injectable drugs, and sexual 
transmission[10]. There is higher seroprevalence of  HDV 
in younger male subjects who are positive for HBsAg.
HDV IN INDIA
In India, the trend is much different from that in Pakistan 
and HDV infection does not seem to be very common. 
It is suggested that the infection is switching towards low 
prevalence in this country[15]. A number of  studies have 
been done in India to estimate the prevalence of  HDV 
infection but there is lack of  a national survey. 
In Northern India, the prevalence of  hepatitis D in 
HBsAg-positive individuals from New Delhi was reported 
to be 8.1% in 1996[16] and 10.6% in 2005[15], which was 
lower than in Chandigarh in Northern India, where the 
infection was reported endemic in 1995 and showed 
a prevalence of  14.2%[17]. In Central India, a study in 
Indore showed higher prevalence of  5.7% in patients 
with chronic liver disease, 1.9% in those with acute viral 
hepatitis, 15% in those with hepatic failure, and 2.3% 
in those with chronic renal failure[18]. In Kolkata, the 
prevalence was found to be 3.3% in 1998[19].
In Mumbai, according to a study done in 1992, the 
HDV prevalence was 37.46% in HBsAg-positive patients. 
There was a higher HDV prevalence of  63% in patients 
with fulminant hepatitis[20]. However, another study from 
this city showed a prevalence of  16% in patients with 
acute viral hepatitis, 17% in asymptomatic HBsAg carriers, 
and 19% in patients with chronic liver disease. Among the 
high-risk population, HDV prevalence was 20% in chronic 
renal failure patients, 29% in medical professionals, 
and 38% in recipients of  multiple transfusions[21]. Delta 
infection in Ludhiana was reported to be 33% in children 
with a high prevalence of  HDV[22]. Another study from 
Ludhiana in the same year showed a prevalence of  10% 
in HBsAg-positive patients[23]. In Southern India, low 
HDV prevalence in patients undergoing hemodialysis was 
reported in a study published in 1991[24]. However, there is 
high prevalence of  HDV in the resident tribes of  Nicobar 
and Andaman islands[25].
HDV IN IRAN
HDV is a major public health issue in Iran[26]. Studies 
from different areas of  the country show varied 
prevalence rates. Although overall HBV, and therefore, 
HDV prevalence might have decreased in Iran, studies 
have indicated an increase in HDV occurrence in HBsAg-
positive patients. Anti-HDV prevalence in asymptomatic 
HBV carriers from Southern Iran was 14% in 1989[27]. A 
recently published study reported a prevalence of  9.7% 
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Figure 1  Hepatitis D prevalence in the Asia-Pacific region.
in chronic HBV patients from Shiraz, which represented 
a decrease in prevalence from 1989[28]. In Midwest Iran, a 
low prevalence of  2.4% in 1989 was reported in HBsAg 
carriers[26]. A study conducted during 1986-1988 has 
estimated the prevalence of  hepatitis D in various high-
risk groups. The prevalence of  anti-delta was found to 
be 2.5% (3/120) in asymptomatic chronic carriers of  
HBsAg, 33.33% (2/6) in hemophilic patients, 44.5% 
(16/36) in HBsAg-positive hemodialysis patients. Five out 
of  eight patients with hepatocellular carcinoma (HCC) 
were also positive for anti-HDV[29]. In 2000, 1.3% of  
blood donors positive for HBsAg and 25.2% of  HBsAg-
positive hemodialysis patients were found to be anti-HDV 
positive[30]. 
In Tehran, HDV prevalence was found to be 5.7% in 
chronic HBV patients in 2004[31]. In Golestan Province, 
Northeastern Iran, a recent study has shown an anti-
HDV prevalence of  5.8% in HBsAg carriers[32]. Another 
study also has shown an HDV prevalence of  5.8% 
(8/139) in this part of  Iran. These studies suggest an 
increase in HDV prevalence over the past decade[33]. 
In Babol, Northern Iran, HDV prevalence was 2% 
in chronic hepatitis B patients in 2002[34]. However in 
Kerman, Southern Iran, HDV prevalence was found to 
be 20.7% in chronic hepatitis B patients[35]. In Tabriz, 
Northwestern Iran in 2000, HDV prevalence was observed 
to be 6.15% in chronic HBV patients[36]. A recently 
published study (2008) has shown a high HDV prevalence 
of  31.57% in HIV/HBV co-infected individuals in 
Kermanshah, Western Iran[37]. 
HDV IN AFGHANISTAN
Not enough data are available from Afghanistan to esti-
mate recent prevalence of  HDV. A study was conducted 
between 1976 and 1984 in which sera were collected 
from 362 persons in various epidemiological groups with 
chronic and acute HBV infection. Some sera were also 
collected from drug addicts and hemophiliacs with an-
tibodies for hepatitis B. It was seen that hepatitis D was 
common in drug addicts, hemophiliacs, hemodialysis 
patients and prisoners. However, HDV was uncommon 
in homosexual men, people with sporadic hepatitis B, 
and in people from other endemic areas for hepatitis B. 
HDV prevalence was 18% in patients with chronic liver 
disease, 2% in asymptomatic carriers of  hepatitis B, and 
5% in acute hepatitis B patients. No infection was ob-
served in institutionalized mentally retarded persons and 
health-care workers. During the 9 years of  the study, no 
change was seen in HDV frequency[38].
HDV IN MAINLAND CHINA
In mainland China, HDV infection is not very prevalent 
but it does exist. The results of  a study done in Sichuan 
Province in 1987 have suggested a low prevalence of  0.8% 
in HBsAg-positive patients, although the prevalence rate 
of  HBV was high[39]. In 1989, the prevalence of  anti-
HDV was 4.3% in Tibet, Inner Mongolia, and Xinjiang, 
whereas no HDV infection was observed in Henan, 
Fujian, Liaoning, Heilongjiang, Guangxi, Sichuan, Beijing 
and Shanghai[40]. In 1990, 2346 liver samples were tested 
from 17 different areas of  China for the intrahepatic 
hepatitis D antigen (HDAg). The observed detection rate 
was 9.47%[41]. 
In the area of  Guangzhou, the prevalence of  HDAg 
in 1990 was 13.3% in adults and 13.6% in children, which 
showed an insignificant difference in prevalence between 
the two age groups[42]. In the area of  Shijiazhuang, the 
prevalence of  HDV infection was observed to be 12.92% 
in 1990 and the study suggested Shijiazhuang as a high-
HDV-prevalence area[43].
In the province of  Henan, a study conducted between 
1991 and 1993 showed that 3.5% of  the HBsAg-positive 
blood samples were anti-HDV positive. The investigators 
did not observe any significant difference of  HDV 
prevalence with sex. However, noteworthy differences 
were observed in different age groups, particularly in 
those aged > 60 years[44]. In Shandong province, 7.72% 
of  the HBsAg-positive patients were found to be anti-
HDV positive in 1998. The prevalence rates were 13.15% 
in patients with hepatitis B and only 3.16% in HBsAg 
carriers[45]. A 2006 study conducted in Wuhan City has 
shown a low prevalence of  HDV infection of  2.22% in 
intravenous drug users. However, the HBV and HCV 
prevalence rates were much higher in this population[46].
HDV IN HONG KONG, CHINA
In Hong Kong, hepatitis D has high prevalence rates 
among intravenous drug abusers (IVDAs). These finding 
were reported by a study that tested the sera of  a large 
number of  patients with acute or chronic HBV infection 
for anti-HDV between January 1988 and December 1990. 
HDV was detected in 13 out of  14 IVDAs, which corre-
sponds to a prevalence of  93% in this group, whereas the 
prevalence was only 0.15% in 664 non-IVDAs[47].
HDV IN TAIWAN, CHINA
Taiwan is considered to be endemic for hepatitis B, but 
as a result of  effective immunization, HBV prevalence 
has decreased markedly. Hepatitis D prevalence in 
Taiwan was very high in the 1990s and before, but the 
prevalence has decreased greatly since then and new 
cases of  HDV infection are now encountered rarely[48].
In 2003, the HDV prevalence in HBsAg carriers was 
15.3% (56/366)[49]. A study published in 1997 identified 
77 patients wit h acute HDV superinfection among 
527 consecutive HBsAg carriers over the past 12 years. 
From June 1983 to May 1995, the prevalence decreased 
considerably by each 3-year period (23.7, 15.5, 13.1 and 
4.2%, respectively). This change in the endemicity might 
have occurred due to the effective preventive measures 
taken against sexually transmitted diseases (STDs) and 
promiscuity and encouragement to use disposable 
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needles[50]. In 1990, a high HDV superinfection prevalence 
of  24.7% (21/85) was observed in HBsAg carriers from 
Southern Taiwan[51].
Prostitutes are considered a high-risk group for 
hepatitis B and D. In 1993, the HDV prevalence in adult 
licensed prostitutes was 55%, 36% in adult unlicensed 
prostitutes, and 16% in teenage unlicensed prostitutes. 
Important factors identified for this high HDV prevalence 
were use of  unsterilized needles for tattooing and ear 
piercing, and frequent sexual contact with multiple 
partners, which resulted in genital ulcers[52]. From 1986 
to 1989, a two fold increase in HDV prevalence was 
observed in prostitutes. However there was no change 
in the HDV prevalence in IVDAs and the general 
population[53]. In 1992, the HDV prevalence in HBsAg 
carriers was 9.6% in STD patients, 33.1% in prostitutes, 
2.2% in blood donors from the general population, and 
68.1% in drug abusers[53].
In 2002, HDV prevalence in IVDAs was 39%. From 
1986 to 1997, a decreasing rate of  4.7% every year was 
observed in this high-risk group[54]. In 1990, 91% (119/131) 
of  the HbsAg-positive IVDAs were found to be positive 
for anti-HDV, which showed an extremely high HDV 
prevalence in this high-risk group[55]. In 1989, 78.5% of  the 
HbsAg-positive parenteral drug abusers tested positive for 
anti-HDV in Southern Taiwan[56]. In 1988, a study showed 
a high HDV prevalence of  85% in 151 IVDAs/HbsAg 
carriers, and in 1986, the results of  a study showed that 
HDAg was detected in 78.9%[19] of  115 IVDAs/HBsAg 
carriers[57,58].
In 1988, a study showed an HDV prevalence of  
10.3% (3/29) in children with acute hepatitis B, and 1.4% 
(1/68) in children with chronic HBV. No asymptomatic 
HBsAg carrier child tested positive for HDV[59].
HDV IN JAPAN
In Japan, certain areas are highly HDV prevalent, 
especially Mikayo Islands in Okinawa[60]. A study published 
in 1990 has assessed the prevalence of  HDV infection 
in Japan at different time periods. Hepatitis D was first 
observed in 1979-1983 and the prevalence was 16% 
in acute hepatitis B, 6.8% in HBV carriers, and 26% in 
chronic liver disease. Anti-HDV was later rarely observed. 
The findings of  this study suggest limited sporadic HDV 
infection in Japan[61]. In 1993, a study compared the HDV 
prevalence rates between area of  high HBV incidence, i.e. 
Kamigoto Islands and an area of  average HBV carriage 
rate, i.e. Oita City. The HDV prevalence in Kamigoto 
Islands was 8.3%, while that in Otia City was 0%. The 
study pointed towards the possible risk of  outbreak of  
this infection in HBV prevalent areas in the future[62]. 
As compared to other parts of  the country, Okinawa 
Islands, especially Miyako Islands, which are located in 
the southernmost part of  the country, are considered 
to be endemic for the virus, where HDV genotype Ⅱb 
is prevalent[60]. In 1995, the HDV prevalence in Miyako 
Islands was 23.5%[63]. In 1998, the HDV prevalence in 
Miyako Islands was 21.1%. It has been suggested that 
the rate of  HDV prevalence is likely to increase with 
increasing age or underlying disease severity[64]. However, 
in 2000, the HDV prevalence further decreased to 8.5% 
among the 4728 inhabitants of  the islands[65].
In Irabu Islands, Okinawa the HDV prevalence 
among HBsAg-positive patients was 23.6% in 1997, 
which indicated another high-prevalence area in Okinawa. 
The incidence rates were different in the seven districts of  
Irabu Islands, and ranged from 0% to 63.3%[66]. 
HDV IN KOREA
In Korea, HDV prevalence was estimated to be 0.85% 
in 1985. In 2003, a study was conducted in which 194 
HBsAg-positive Korean patients were tested for anti-
HDV, out of  which, seven (3.6%) tested positive. Six of  
these patients had HCC and one had cholangiocarcinoma. 
Therefore, HDV was mainly associated with patients with 
HCC with a prevalence rate of  approximately 4%, which 
has not changed greatly during the past 20 years[67].
HDV IN INDONESIA
In Indonesia, only a few studies are available on the 
prevalence of  HDV, thus, this infection does not seem 
to be a major problem in this area unlike some other 
Asian countries. A study published in 1988 assessed 
the prevalence of  hepatitis D in pregnant women in 
Bandung, a densely populated area of  Indonesia. Out of  
the 926 pregnant women included in the study, only 2.8% 
(26) were carriers of  HBsAg, among which, none tested 
positive for delta antibodies in spite of  the fact that in 
this Indonesian population, HbsAg was frequent[68]. 
However, in 2003, the prevalence was found to be < 0.5% 
in the HBsAg carriers of  Surabaya, which is also very 
low[69].
HDV IN MALAYSIA
In Malaysia, hepatitis D was first described in 1986 in 
some population groups. The HDV prevalence was 
found to be 12.5% in cases of  acute hepatitis B, 6.7% 
in homosexual individuals, and 17.8% in drug abusers 
who were positive for HBsAg[70]. In 1989, the HDV 
prevalence was found to be 4.9%[71]. In 1996, 0.9% of  
the 923 jaundiced patients were found to be positive 
for anti-HDV[72]. In 1985, surveillance results for the 
detection of  anti-HDV in IVDAs showed an absence of  
anti-HDV. However, in 1986, a prevalence of  17.8% was 
observed in the same group. The prevalence increased 
to 20% in 1989 and in 1994, 34% of  the drug addicts 
tested positive for anti-HDV[73].
HDV IN THAILAND
In Thailand, hepatitis D is prevalent among IVDAs, a 
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high-risk group for viral hepatitis. A study conducted in 
1988 tested 84 HBsAg-positive IVDAs, of  which, 65.48% 
showed anti-HDV positivity. The HDV prevalence in 20 
chronic hepatitis patients was 11.11% and 8.33% in 12 
cirrhotic patients. No anti-delta antibodies were detected 
in 46 asymptomatic carriers[74]. A study in 2002 tested 55 
HBsAg-positive sera of  IVDAs, among which, 12 (21.8%) 
tested positive for anti-HDV. Among these anti-HDV-
positive sera, eight (66%) tested positive for HDV RNA, 
and all had genotype Ⅰ virus[75]. 
Another study in 2002 tested 269 sera from the 
Hmong people of  Northern Thailand for the seropreva-
lence of  viral hepatitis. Despite the high seroprevalence 
of  76.0% for hepatitis B, the seropositivity of  HDV was 
only 0.7%[76]. 
HDV IN PHILIPPINES
A study was conducted in 1990 to estimate the prevalence 
of  HDV. Of  the 64 patients with acute viral hepatitis, 1.6% 
tested positive for HDV. HBV was present in 40.6% of  
the acute viral hepatitis patients[77].
HDV IN VIETNAM
Vietnam is considered to be highly endemic for hepatitis 
B, which is one of  the most important public health 
concerns. In order to estimate the prevalence of  HBV 
and HDV in this area, a cross-sectional seroprevalence 
study was conducted in Thai Binh Province in 2007. 
Nineteen percent of  the samples were HBsAg-positive, 
out of  which, 1.3% were positive for HDV[78]. Thus, 
HDV does not seem to be prevalent in this HBV-
endemic area. The results of  another study conducted 
in Ho Chi Minh City in 2003 has shown that, except for 
HDV, other hepatitis viruses are spreading among the 
patients with liver diseases[79].
HDV IN AUSTRALIA
A study was conducted in Melbourne to establish the 
epidemiology of  hepatitis D over a period of  15 years. 
Three thousand nine hundred and eighty-six HbsAg-
positive patients were tested for HDV markers between 
1971 and 1985. Hepatitis D markers were detected 
mostly in IVDAs and among their close contacts, and 
the results suggested the introduction of  HDV in this 
group in 1970. The delta infection prevalence in carriers 
with no chronic liver disease was the highest (19.2%) 
among the IVDAs. Out of  the 23 carriers with recurrent 
acute hepatitis, all tested positive for HDV markers and 
20.1% of  the carriers with chronic liver disease tested 
positive for the HDV markers[80].
Apart from IVDAs, homosexual men are another 
high-risk group for HBV and HDV. In a study from 
Sydney in 1989, 204 homosexual men with acute or 
chronic HBV were tested for markers of  HDV (total 
antibody to delta and delta antigen). Eight tested positive 
for total antibody to delta, whereas delta antigen was 
detected in only one of  the tested individuals, which 
showed a total HDV prevalence of  4.4%. All individuals 
who tested positive for the markers were IVDAs[81].
PACIFIC ISLANDS
Kiribati is an island located in the central tropical Pacific 
Ocean. HDV prevalence in this island is said to be very 
high. A serological survey was undertaken between 
May 1985 and February 1986 in which blood samples 
collected from 13 different places of  the Southeast 
Asia and Pacific region were tested for HIV, HBV and 
HDV. The maximum HDV prevalence was observed in 
Kiribati, which was 84% in HBsAg-positive patients[82]. 
Another study in 1989 reported a prevalence of  69% 
(90/130) in individuals infected with HBV[83].
Nauru, an isolated Pacific Island is considered 
hyperendemic for HDV. High HDV prevalence was 
reported here in 1986, in a study in which 2645 HBsAg-
positive patients from several places in the Western Pacific 
were tested for HDV[84]. According to the results of  a 
national epidemiological survey, published in 1989, in 
which 88% of  the population was screened for HBV and 
HDV, 69.1% were reported positive for HBV markers, 
whereas HDV superinfection was observed in 22.7% of  
hepatitis B carriers[85]. 
HDV IN SAUDI ARABIA
HDV prevalence in Saudi Arabia was 8% (3/36) in 
HBsAg carriers in 1986[86]. The prevalence in the Riyadh 
area in the same year was 22.2% in patients with chronic 
hepatitis B, 7.9% in those with acute hepatitis B, and 6.7% 
in HBsAg carriers. In Najran, the prevalence was 9.6% in 
HBsAg carriers, and 5.3% in Al-Hafouf. In the areas of  
Khaiber and Jaizan, no anti-delta was found in the tested 
HBsAg carriers[87]. In 1987, a high HDV prevalence of  
32% was detected in HBsAg-positive Saudi patients with 
liver disease, while the prevalence was 13% in patients 
with other illnesses. In healthy individuals, the prevalence 
was found to be 5.4%[88]. In 1988, the prevalence was 
8% in HBsAg carriers in Gizan, an area considered 
hyperendemic for HBV[89]. A prevalence rate of  9.7% 
was detected in HBsAg-positive pregnant women in 
1988. However, follow-up of  17 infants showed no 
indication of  perinatal transmission[90]. In 1991, the 
prevalence in HBsAg-positive patients was found to be 
17.6%[91]. In 1998, a study conducted in Jeddah showed 
an HDV prevalence of  13.6%. The HDV prevalence in 
IVDAs/carriers of  HBsAg was 14.7% while there was 
0.0% prevalence in non-IVDAs positive for HbsAg[92].
In 2004, the HDV prevalence among HBsAg-
positive healthy donors was 3.3%, while that in clinic- 
and hospital-based HBsAg patients was 8.6%. HDV 
infection is expected to decrease in Saudi Arabia with 
decreasing HBV prevalence due to global vaccination[93].
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HDV IN OMAN 
In Oman, according to a study conducted in 1991, the 
HDV prevalence was 7.7% (1/13) in HBsAg-positive 
dialysis patients and 22.2% (2/9) in HBsAg-positive 
renal transplant patients who have been previously trans-
fused[94]. In 1994, HbsAg was detected in 11% of  patients 
with kidney transplants and 12.7% of  patients on dialysis. 
Anti-HDV was detected only in one HBsAg-positive pa-
tient on dialysis and two HbsAg carriers with renal trans-
plants, which shows a low HDV prevalence among these 
patients[95].
HDV IN LEBANON
Hepatitis D was first detected in Lebanon in 1987 when 
a study reported 57% HDV prevalence in patients with 
chronic active hepatitis[96]. In 2007, the results of  a study 
in which 258 HBsAg-positive patients from 10 health 
centers were included showed 1.2% (3/258) HDV 
prevalence, which shows a decrease in prevalence since 
1987[97]. 
HDV IN TURKEY
In Turkey, like many other countries, a decline in HDV 
infection has been observed, but it is still a significant 
public health concern[98]. A recently published meta-
analysis of  HDV seropositivity has shown the decline in 
HDV infection but also points to the significant health 
concern in low socioeconomic parts of  the country[99]. 
HDV prevalence is much higher in the southeast of  the 
country, being 27% in chronic hepatitis B patients and 
46% in hepatitis-B-induced cirrhosis patients. This is in 
comparison to the HDV prevalence in the West of  the 
country of  5% in chronic hepatitis B patients and 20% in 
hepatitis-B-induced cirrhosis patients. The analysis also 
compared prevalence of  HDV before and after 1995. It 
was observed that HDV prevalence in chronic hepatitis B 
patients decreased from 38% to 27% in Southeast Turkey 
and from 29% to 12% in Central Turkey. HDV prevalence 
in cirrhosis patients has decreased from 66% to 46% in 
Southeast and from 38% to 20% in West Turkey[99]. 
CONCLUSION
The prevalence of  hepatitis D shows a decreasing trend 
due to preventive measures like vaccination against 
hepatitis B and awareness campaigns with regard to 
risk factors for the transmission of  hepatitis B and 
D. Although preventive measures against hepatitis B 
including vaccination have decreased the prevalence 
of  hepatitis D, there is no effective way of  preventing 
HDV infection in HBV carriers in endemic areas. This 
can only be achieved by educating such individuals to 
prevent further exposures to risk factors. In spite of  
the global trend of  decline, significant and persistent 
transmission is present in some countries. 
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